Several bacterial avr genes have been shown to contribute to virulence on susceptible plants lacking the corresponding resistance (R) gene. The mechanisms by which avr genes promote parasitism and disease, however, are not well understood. We investigated the role of the Pseudomonas syringae pv. tomato avrRpt2 gene in pathogenesis by studying the interaction of P. syringae pv. tomato strain PstDC3000 expressing avrRpt2 with several Arabidopsis thaliana lines lacking the corresponding R gene, RPS2. We found that PstDC3000 expressing avrRpt2 grew to significantly higher levels and often resulted in the formation of more severe disease symptoms in ecotype No-0 plants carrying a mutant RPS2 allele, as well as in two Col-0 mutant lines, cpr5 rps2 and coi1 rps2, that exhibit enhanced resistance. We also generated transgenic A. thaliana lines expressing avrRpt2 and demonstrated, by using several different assays, that expression of avrRpt2 within the plant also promotes virulence of PstDC3000. Thus, AvrRpt2 appears to promote pathogen virulence from within the plant cell.
Disease resistance in plants is often dependent on the plant's ability to specifically recognize invading pathogens. This mechanism of resistance is controlled at the genetic level and is governed by disease-resistance (R) genes that confer on the plant the ability to recognize pathogen strains expressing specific avirulence (avr) genes (Baker et al. 1997) . Historically, pathogen avr genes have been thought to encode or direct the production of molecules that elicit the rapid induction of defense responses on resistant host plants Dangl 1994; Leach and White 1996; Vivian and Gibbon 1997) . Their prevalence suggests, however, that avr genes also must provide a selective advantage for the pathogen, and it has been proposed that a primary function of bacterial Avr proteins is to promote pathogen growth and disease development on susceptible host plants Dangl 1994; Leach and White 1996; Vivian and Gibbon 1997) . Accordingly, several bacterial avr genes have been demonstrated to contribute to virulence on susceptible plant lines lacking the corresponding R gene (Jackson et al. 1999; Kearney and Staskawicz 1990; Lorang et al. 1994; Ritter and Dangl 1995; Swarup et al. 1991) . The function of Avr proteins and the mechanisms by which they promote parasitism and disease, however, are not well understood.
Genetic analysis of bacterial plant pathogens has demonstrated that the function of many bacterial avr genes depends on the pathogen hrp/hrc genes, which are predicted to encode a specialized (Type III) protein secretion apparatus that mediates transfer of bacterial proteins into the cytosol of the host cell (Alfano and Collmer 1997; Galan and Collmer 1999) . Additionally, several Avr proteins have been shown to function within plant cells, where they elicit host defense responses on plants carrying a corresponding R gene (Bonas and Van den Ackerveken 1997; Duan et al. 1999; Kjemtrup et al. 2000; Leister et al. 1996; McNellis et al. 1998; Stevens et al. 1998; Tobias et al. 1999) . These results provide compelling evidence that in many cases bacterial Avr proteins are delivered directly into plant cells, where they trigger defense responses in resistant hosts.
We are interested in learning more about the role of the Pseudomonas syringae pv. tomato avrRpt2 gene (Dong et al. 1991; Innes et al. 1993; Whalen et al. 1991) in pathogenesis. P. syringae strains expressing avrRpt2 rapidly induce host defense responses on Arabidopsis thaliana plants carrying a functional copy of the corresponding R gene, RPS2, and are thus unable to multiply to high levels or cause disease in these plants Yu et al. 1993) . Much emphasis has been placed on elucidating the signaling mechanism by which avrRpt2/RPS2-mediated pathogen recognition activates these defense responses (Boch et al. 1998; Innes et al. 1993; Leister et al. 1996; McNellis, et al. 1998; Mudgett and Staskawicz 1999; Reuber and Ausubel 1996) . The possibility that avrRpt2 also may contribute to virulence on susceptible plants has not been explored.
One clue as to a possible mechanism by which avrRpt2 could function to promote pathogenesis is provided by the discovery that P. syringae expressing avrRpt2 can interfere with induction of avrRpm1/RPM1-mediated resistance (Ritter and Dangl 1996) . These findings suggest that avrRpt2 can Z. Chen and A. Kloek contributed equally to this work and are joint first authors.
modify host defense signaling pathways in resistant hosts. It has yet to be determined, however, whether avrRpt2 might function via a similar mechanism to promote virulence in susceptible plants.
Here we show that, in the absence of RPS2 in the plant, avrRpt2 acts as a virulence factor that promotes growth of P. syringae pv. tomato strain DC3000 (PstDC3000) in several different A. thaliana ecotypes and mutants that exhibit varying degrees of resistance to P. syringae. We also demonstrate that transgenic A. thaliana plants expressing avrRpt2 exhibit enhanced susceptibility to PstDC3000. These results indicate that AvrRpt2 functions inside the plant cell to promote bacterial virulence.
RESULTS
Expression of avrRpt2 in PstDC3000 enhances pathogen virulence in A. thaliana lines lacking the corresponding resistance gene, RPS2.
To test the hypothesis that avrRpt2 promotes parasitism and disease in plant hosts lacking a functional RPS2 gene, we compared the virulence properties of two P. syringae pv. to- Fig. 1 . Disease symptoms and growth of Pseudomonas syringae pv. tomato strain DC3000 (PstDC3000) on Arabidopsis thaliana leaf tissue. A, Disease symptoms caused by PstDC3000 on A. thaliana No-0 rps2 (top) and Col-0 rps2 (bottom) plants. Leaves are shown 4 days after inoculation with PstDC3000 (left) and PstDC3000(avrRpt2) (right). Plants were inoculated by dipping them into bacterial suspensions (3 to 5 × 10 8 CFU/cm 2 ) containing the surfactant Silwet L-77. B, Growth of PstDC3000 and PstDC3000(avrRpt2) in leaf tissue of Col-0 rps2, No-0 rps2, and No-0 RPS2 plants. C, Growth of PstDC3000 and PstDC3000(avrRpt2) in leaf tissue of Col-0 (CPR5) rps2 and cpr5-2 rps2 plants. D, Growth of PstDC3000 and PstDC3000(avrRpt2) in leaf tissue of Col-0 (COI1) rps2 and coi1-20 rps2 plants. In B, C, and D, A. thaliana plants were inoculated by vacuum infiltration with the indicated PstDC3000 strains at an initial density of 1 × 10 5 CFU/cm 2 . The concentration of bacteria in the plant leaves was assayed after 0, 2, and 4 days. Data points represent means of three independent determinations ± standard error of the mean. Experiments presented in A, B, and C were carried out a minimum of three times with similar results. For the experiment in D, similar results were obtained in a second independent experiment. The drop in cell number observed on day 4 in No-0 and coi1-20 plants inoculated with PstDC3000 is reproducible and has been observed in several independent experiments.
mato strains: PstDC3000 and the isogenic PstDC3000 strain expressing avrRpt2 [PstDC3000(avrRpt2)]. On Columbia (Col-0) plants carrying a mutation at the RPS2 locus, infection with PstDC3000(avrRpt2) did not reproducibly result in more severe disease symptoms or increased pathogen growth when compared with infection with PstDC3000 (Figs. 1A and B) Yu et al. 1998 ). Because PstDC3000 is very virulent on Col-0, it is possible that the presence of an additional potential virulence factor such as avrRpt2 does not significantly increase the virulence of this strain on this host. To facilitate detection of a potential role in virulence for avrRpt2, we studied the effect of avrRpt2 in interactions with several less-susceptible A. thaliana lines. These included the A. thaliana ecotype Nossen (No-0) and two Col-0 mutant lines that exhibit enhanced resistance to infection by P. syringae.
We chose to work with No-0 because this ecotype is only moderately susceptible to infection by PstDC3000 . To investigate the role of avrRpt2 in virulence, we generated a line of No-0 carrying a mutation at the RPS2 locus by introgressing the rps2-201C mutant allele, which was originally isolated in the Col-0 ecotype (Bent et al. 1994; Kunkel et al. 1993) , into No-0. Infection of No-0 rps2 plants with PstDC3000 resulted in mild disease symptoms and moderate levels of bacterial growth (Figs. 1A and B) . Inoculation with PstDC3000 did not cause severe disease on No-0 rps2 plants, yet the response of these plants to PstDC3000 infection was distinct from that observed in typical resistant interactions. The level of growth achieved by PstDC3000 on No-0 rps2 plants was 50-to 100-fold higher than that observed in No-0 RPS2 plants infected with PstDC3000(avrRpt2) (Fig.  1B) . Furthermore, inoculation with high levels of PstDC3000 did not elicit a macroscopic hypersensitive response (HR; Table 1 ), one of the hallmarks of disease resistance characterized by the rapid, localized collapse of leaf tissue surrounding the site of infiltration (Baker et al. 1997; Hammond-Kosack and Jones 1996; Morel and Dangl 1997) . The genetic and molecular bases of this partially susceptible phenotype are not well understood and are currently under investigation.
Inoculation with PstDC3000 expressing avrRpt2 resulted in significantly more severe disease symptoms on No-0 rps2 plants (Fig. 1A) . Growth of PstDC3000(avrRpt2) in No-0 rps2 plant tissue also was significantly increased, reaching population levels 50-to 100-fold higher than those observed for PstDC3000 (Fig. 1B) . The severity of disease symptoms and the level of pathogen growth were similar to that observed for Col-0 rps2 plants inoculated with either strain (Figs. 1A  and B) . The elevated level of PstDC3000(avrRpt2) growth relative to PstDC3000 was maintained for at least 8 days after inoculation (data not shown). In addition, most plants inoculated with PstDC3000(avrRpt2) were severely stunted and died within 2 to 3 weeks after infection, whereas plants inoculated with PstDC3000 usually recovered. Thus, the expression of avrRpt2 significantly enhances the virulence of PstDC3000 on No-0 rps2 plants by promoting both bacterial growth and disease symptom production.
To determine whether avrRpt2 virulence activity is specific for the No-0 ecotype or whether avrRpt2 also promotes growth and/or disease production in other ecotypes, we tested whether avrRpt2 could enhance virulence of PstDC3000 in interactions with mutants isolated in the Col-0 genetic background and that exhibit enhanced disease resistance. In these studies, we used two resistance mutants, previously isolated in our laboratory, that carry the rps2-201C mutation. The first was the cpr5-2 mutant, which exhibits resistance to multiple pathogens as a result of constitutive expression of defense responses (Boch et al. 1998; Bowling et al. 1997) . The second mutant, coi1-20, carries a newly identified allele of the coronatine-insensitive (COI1) locus and exhibits enhanced resistance to virulent P. syringae strains, presumably as a result of its insensitivity to the bacterial toxin coronatine (Feys et al. 1994; A. Kloek and B. Kunkel, unpublished) .
Growth of PstDC3000 was significantly restricted in cpr5 rps2 and coi1 rps2 plants (Figs. 1C and D) , and infection with PstDC3000 did not result in the development of visible disease symptoms on either plant line (Boch et al. 1998 , and data not shown). In contrast, PstDC3000(avrRpt2) grew to significantly higher levels in both mutants, obtaining final concentrations of 10-to 50-fold higher than those observed for PstDC3000 (Figs. 1C and D) . In these experiments, infection with PstDC3000(avrRpt2) did not usually give rise to severe disease symptoms, presumably because expression of avrRpt2 was not sufficient to promote pathogen growth to the high levels associated with tissue damage and lesion formation. These results demonstrate that expression of avrRpt2 promotes the growth of PstDC3000 in plant mutants that exhibit enhanced disease resistance. Furthermore, our findings indicate that avrRpt2 virulence activity is not specific to interactions between PstDC3000 and ecotype No-0.
An additional example of avrRpt2 virulence activity, in which avrRpt2 promotes the virulence of P. syringae strains carrying avrRpm1 on normally resistant A. thaliana plants carrying the corresponding R gene RPM1, has previously been reported (Ritter and Dangl 1996) . In a series of elegant experiments, Ritter and Dangl demonstrated that avrRpt2 interferes with several avrRpm1/RPM1-mediated resistance responses, including induction of the HR, activation of defense gene expression, and restriction of bacterial growth. These results are consistent with our observations and indicate that expression of avrRpt2 promotes pathogen growth in a variety of P. syringae-A. thaliana interactions.
Transgenic plants expressing avrRpt2 exhibit enhanced susceptibility to PstDC3000.
Several bacterial Avr proteins, including AvrRpt2, have been shown to function inside plant cells, where they trigger R gene-mediated defense responses (Bonas and Van den Ackerveken 1997; Leister et al. 1996; McNellis et al. 1998) . Presumably, any virulence activity of these Avr proteins would also be active within plant cells. Consistent with this hypothesis are reports that expression of high levels of some Avr proteins results in the death of the host tissue in plant cells lacking the corresponding R gene (Duan et al. 1999; Gopalan et al. 1996; McNellis et al. 1998; Tobias, et al. 1999 ). It has not been established, however, whether the cell death induced by expression of these Avr proteins reflects a role in virulence.
To explore the possibility that AvrRpt2 functions within plant cells to promote virulence, we studied the interaction between PstDC3000 and transgenic A. thaliana plants expressing avrRpt2. Two different avrRpt2 transformation constructs were made. The first was generated by placing the avrRpt2 coding region under the transcriptional control of the Cauliflower mosaic virus (CaMV) 35S promoter (p35S-avrRpt2) and then introduced into No-0 rps2-201C plants by Agrobacterium-mediated transformation (Clough and Bent 1998) . The second construct was generated by placing avrRpt2 under the control of the A. thaliana RPS2 regulatory region (pRPS2-avrRpt2) and then used to transform Col-0 rps2-101C plants (Leister et al. 1996) . Several lines homozygous for single-locus insertions of the transgenes were isolated in each case and then selected for further characterization. Transgenic No-0 rps2 lines homozygous for the empty transformation vector also were generated as controls. Expression of avrRpt2 in several of the transgenic lines was verified by RNA gel blot analysis, as well as by testing for expression of the avrRpt2 gene by monitoring for RPS2-dependent (e.g., HR-induced) seedling death in F 1 plants generated by crossing the transgenic lines to plants carrying a functional RPS2 allele (data not shown). Expression of avrRpt2 in the transgenic plants we obtained did not appear to be detrimental as the transgenic plants were healthy and green. Several of the transgenic lines were slightly smaller than the untransformed parental plants or plants carrying the vector only, an observation that may reflect one or more physiological alterations caused by the avrRpt2 transgene (data not shown). The potential effects of avrRpt2 expression on plant physiology are under investigation.
The transgenic lines expressing avrRpt2 were more susceptible to infection by PstDC3000 than were the control transgenic lines or the parental lines ( Figs. 2A and B) . The increased susceptibility in the No-0 rps2 plants expressing avrRpt2 was apparent in the development of significantly more severe disease symptoms ( Fig. 2A ) and in the higher concentration of bacteria present by the fourth day after inoculation (Fig. 2C ). Although PstDC3000(avrRpt2) was not detectably more virulent than PstDC3000 on Col-0 rps2 plants, transgenic Col-0 rps2 plants expressing avrRpt2 developed more severe disease symptoms after infection with PstDC3000 than did the untransformed Col-0 rps2 plants (Fig.  2B ). However, as the level of growth of PstDC3000 is already very high in Col-plants, we did not observe a significant increase in bacterial growth in the transgenic Col-0 rps2 plants expressing avrRpt2 (data not shown).
The ability of the avrRpt2 transgene to promote pathogen virulence was further tested by crossing the pRPS2-avrRpt2 construct from a Col-0 rps2 transgenic line into cpr5 rps2 plants. The resulting cpr5 rps2 lines expressing avrRpt2 supported levels of bacterial growth that were significantly higher than those of the parental cpr5 rps2 line (Fig. 2D) . Thus, expression of avrRpt2 in transgenic plants provides avrRpt2 virulence activity in trans to PstDC3000, a result indicating that AvrRpt2 functions inside the plant cell to promote symptom production and pathogen growth and/or persistence within the leaf tissue.
Expression of avrRpt2 in transgenic plants inhibits RPM1-mediated resistance responses.
As an independent assay for avrRpt2 virulence activity inside plant cells, we tested whether expression of avrRpt2 in transgenic A. thaliana plants could interfere with avrRpm1/RPM1-mediated resistance. Col-0 rps2 and No-0 rps2 plants, both of which naturally carry functional alleles of RPM1, are resistant to PstDC3000 strains expressing avrRpm1 [PstDC3000(avrRpm1)] and exhibit typical resistance responses after infection by this strain. These responses include restriction of bacterial growth (Fig. 3) , absence of disease symptoms (data not shown), and macroscopic tissue collapse, indicative of the HR when high doses of PstDC3000(avrRpm1) are infiltrated into the leaf (Table 1) (Debener et al. 1991) .
In No-0 rps2 and Col-0 rps2 transgenic plants expressing avrRpt2, we observed strong inhibition of avrRpm1/RPM1-mediated resistance responses. PstDC3000(avrRpm1) grew to high levels in transgenic leaf tissue (Fig. 3) and caused severe disease symptoms (data not shown). In addition, inoculation with high doses of PstDC3000(avrRpm1) failed to trigger an HR in these plants (Table 1) . Thus, the interference of avrRpt2 with expression of avrRpm1/RPM1-mediated resistance responses also appears to occur inside the plant cell. These results are consistent with previous observations that this interference occurs outside of the bacterial cell (Ritter and Dangl 1996) and support the prediction that some Avr proteins such as AvrRpt2 may act inside the plant cell to suppress host defense responses Vivian and Gibbon 1997) .
Expression of avrRpt2 in transgenic plants does not inhibit RPS4 and RPS5 mediated resistance.
To address whether AvrRpt2 interferes with other R genemediated resistance responses, we monitored the ability of avrRpt2 transgenic plants to mount defense responses upon infection by PstDC3000 expressing one of three additional avr genes: avrB, avrRps4, and avrPphB. Recognition of bacteria expressing avrB also is governed by the RPM1 gene (Bisgrove et al. 1994) , whereas resistance to strains expressing avrRps4 and avrPphB is mediated by RPS4 and RPS5, respectively (Hinsch and Staskawicz 1996; Simonich and Innes 1995) . As with the avrRpm1-mediated HR, transgenic plants expressing avrRpt2 failed to mount an HR upon inoculation with PstDC3000(avrB) ( Table 1 ), indicating that avrRpt2 also interferes with the avrB-mediated HR. These plants also exhibited significant disease symptoms upon infection with PstDC3000-(avrB) (data not shown). In contrast, we observed that transgenic plants expressing avrRpt2 retained the ability to exhibit a normal HR when inoculated with PstDC3000(avrRps4) or PstDC3000(avrPphB) ( Table 1) . We were also unable to detect interference between avrRpt2 and either avrRps4 or avrPphB in experiments in which nontransgenic plants were inoculated with P. syringae carrying both avr genes (data not shown).
Although Col-0 plants carry a functional RPS4 gene (Hinsch and Staskawicz 1996) , in our experiments we found that Col-0 rps2 plants failed to exhibit rapid tissue collapse indicative of an HR when inoculated with PstDC3000-(avrRps4) ( Table 1) . This result may not be surprising, given that RPS4-mediated resistance in Col-0 plants is associated with a less-robust HR than that observed in other ecotypes (W. Gassman, M. Hinsch, and B. Staskawicz, personal communication) . We also found that No-0 and No-0 rps2 plants do not possess a functional RPS5 gene because they developed disease symptoms when inoculated with PstDC3000(avrPphB) and exhibited no HR when challenged with high levels of PstDC3000(avrPphB) (Table 1 and data not shown) .
The results from the HR experiments indicate that, among the gene-for-gene interactions we have assayed, AvrRpt2 interferes only with HRs induced upon RPM1-mediated pathogen recognition. These results also indicate that the transgenic plants expressing avrRpt2 retain the ability to exhibit an HR when challenged with certain PstDC3000 strains and are thus not compromised in their ability to mount this defense response.
To determine whether the HRs induced in the transgenic plants expressing avrRpt2 are indicative of induction of pathogen resistance, we monitored the growth of PstDC3000-(avrRps4) and PstDC3000(avrPphB) in transgenic Col-0 rps2 plants expressing avrRpt2. The growth of PstDC3000 expressing either avr gene was significantly lower than that observed for the virulent PstDC3000 strain (Fig. 4A) . Thus, expression of avrRpt2 in transgenic plants does not prevent the induction of either avrRps4/RPS4-or avrPphB/RPS5-mediated resistance.
Interestingly, we did observe that the level of growth of PstDC3000(avrRps4) and PstDC3000(avrPphB) was reproducibly higher in the transgenic plants expressing avrRpt2 than in the nontransgenic control plants (Fig. 4B) . In addition, the transgenic plants did sometimes develop mild disease symptoms, consisting of chlorosis and a few isolated watersoaked lesions, upon infection with these strains (data not shown). Thus, even in these resistant interactions, in which the restriction of bacterial growth (and elicitation of the HR in the case of Col-0 rps2 transgenic plants) indicates that the avr/R gene-mediated resistance responses are triggered, expression of avrRpt2 promotes pathogen virulence within the resistant host tissue.
DISCUSSION
avrRpt2 acts as a virulence factor in PstDC3000.
We have shown that in the absence of a functional copy of RPS2, avrRpt2 functions to promote virulence of PstDC3000 on a variety of different A. thaliana plant lines. This includes promoting pathogen growth and symptom production in the partially susceptible ecotype No-0, as well as enhancing the growth of PstDC3000 in two Col-0 mutants that exhibit resistance to P. syringae (cpr5-2 and coi1-20). Our findings extend the previous discovery made by Ritter and Dangl that expression of avrRpt2 in P. syringae interferes with avrRpm1/RPM1-mediated resistance in A. thaliana (Ritter and Dangl 1996) . Thus, avrRpt2 can be added to the growing list of pathogen avr genes that also function as virulence (vir) factors on susceptible host plants lacking the corresponding R gene (Dangl 1994; Jackson et al. 1999; Leach and White 1996; Shan et al. 2000) .
Like many other avr/vir genes described to date (Lorang et al. 1994; Lorang and Keen 1995; Shan et al. 2000) , the effect Fig. 2 . Disease symptoms and growth of Pseudomonas syringae pv. tomato strain DC3000 (PstDC3000) on transgenic plants expressing avrRpt2. A, PstDC3000 disease symptoms 4 days postinoculation on No-0 rps2 plants transgenic for the empty transformation vector pMON10098 (left) or No-0 rps2 carrying the p35S-avrRpt2 construct (right). B, PstDC3000 disease symptoms 5 days postinoculation on Col-0 rps2 plants (left) or Col-0 rps2 carrying the pRPS2-avrRpt2 construct (right). C, Growth of PstDC3000 in two independent No-0 rps2 transgenic lines carrying the p35S-avrRpt2 construct (squares and triangles) or in No-0 rps2 plants transgenic for pMON10098 (circles). D, Growth of PstDC3000 in cpr5-2 rps2 (circles) and cpr5-2 rps2 plants carrying the pRPS2-avrRpt2 construct (squares). For comparison, growth of PstDC3000 on Col-0 (CPR5) rps2 plants (triangles) also is shown. For assessment of disease symptom production plants were inoculated by dipping them into bacterial suspensions (3 to 5 × 10 8 CFU/cm 2 ) containing the surfactant Silwet L-77. C and D, Arabidopsis thaliana plants were inoculated by vacuum infiltration with the indicated PstDC3000 strains at an initial density of 1 × 10 5 CFU/cm 2 . Data points represent means of three independent determinations ± standard error of the mean. Similar results were obtained in a second independent experiment. of avrRpt2 can be very subtle, contributing only quantitatively to the virulence of PstDC3000 on some host plants (e.g., Col-0 rps2; Figs. 1A and B). One possible explanation for these results is that virulence is provided by a large number of redundant factors (Kjemtrup et al. 2000) and that, in many cases, adding (or removing) a single virulence factor from a very aggressive pathogen strain may result in little or no alteration in virulence on its preferred host. We found that our ability to detect the virulence activity of avrRpt2 was facilitated by studying the interaction of PstDC3000(avrRpt2) with different A. thaliana ecotypes or mutants that exhibited varying degrees of resistance to infection by PstDC3000. Thus, because PstDC3000 is not fully virulent on these lines, any increase in virulence provided by avrRpt2 can be more readily detected. This approach also may prove to be useful for researchers who wish to investigate the function of other avr genes or potential virulence factors in pathogenesis.
AvrRpt2 functions inside plant cells to promote virulence of PstDC3000.
To determine whether AvrRpt2 functions within the plant to promote bacterial virulence, we generated transgenic A. thaliana lines expressing avrRpt2. In these experiments, we demonstrated that expression of avrRpt2 in the plant conferred enhanced susceptibility to infection by PstDC3000 in several different interactions. No-0 rps2 and Col-0 rps2 transgenic plants expressing avrRpt2 exhibited more severe disease symptoms upon infection with PstDC3000. In No-0 rps2 plants, this was also associated with reproducibly higher levels of pathogen growth in the transgenic plant tissue. Likewise, expression of avrRpt2 in transgenic plants promoted the growth of PstDC3000 on cpr5 rps2 mutant plants that exhibit enhanced resistance to P. syringae (Fig. 2C) , as well as the growth of avirulent PstDC3000 strains expressing avrRpm1, avrRps4, or avrPphB (Figs. 3 and 4) . Because the avrRpt2 transgene encodes a cytoplasmic protein that lacks a secretion signal (Bent et al. 1994; Leister et al. 1996; Mindrinos et al. 1994 ), it appears that AvrRpt2 functions within plant cells to promote pathogenesis on susceptible plants lacking RPS2. This is the first example that we know of in which an avr gene product has been shown to promote pathogen virulence from within the plant.
In the majority of the interactions between PstDC3000 strains and transgenic plants expressing avrRpt2 that we studied, we observed a moderate increase in pathogen growth (approximately 10-to 50-fold) within the transgenic plants. These findings suggest that, in most cases, the expression of avrRpt2 enables PstDC3000 to partially suppress or overcome the plant defense responses that prevent bacterial growth and/or symptom production. In the case of RPM1-mediated resistance, however, the virulence effect of avrRpt2 was much more dramatic. In No-0 rps2 and Col-0 rps2 transgenic plants, the expression of avrRpt2 appeared to completely inhibit both the RPM1-mediated HR and restriction of pathogen growth (Table 1 and Fig. 3 ). These results suggest that, in this particular case, AvrRpt2 acts inside the plant cell to promote virulence by inhibiting a very early step in the RPM1-dependent defense signaling pathway. Interestingly, among the known avr/R gene interactions we have assayed to date, AvrRpt2 appears to interfere specifically with RPM1-dependent pathogen recognition events because transgenic plants expressing avrRpt2 retained the ability to mount both an HR and an effective resistance response when challenged with PstDC3000 expressing avrRps4 or avrPphB (Table 1 and Fig. 4) .
What are the possible mechanisms by which avrRpt2 functions to promote virulence of PstDC3000? As discussed, we have observed that PstDC3000(avrRpt2) grows to significantly higher levels than PstDC3000 in No-0 rps2, cpr5 rps2, and coi1 rps2 plants. In all three lines, the plants exhibit en- hanced disease resistance to PstDC3000 in the absence of any known avr/R gene interaction. In cpr5 rps2 and coi1 rps2 mutants, resistance is attributed to the partially deregulated expression of defense responses in the absence of R-gene mediated pathogen recognition (Boch et al. 1998; Bowling et al. 1997; A. Kloek and B. Kunkel, unpublished) . In addition, although avrRpt2 does not appear to interfere with RPS4 or RPS5-mediated induction of defense responses, we observed enhanced growth of PstDC3000 carrying avrRps4 or avrPphB in transgenic plants expressing avrRpt2 (Fig. 4B) . Thus, the ability of avrRpt2 to promote pathogen virulence cannot be attributed solely to interference with resistance mediated by known avr/R gene interactions. This mechanism can explain the apparently complete inhibition of RPM1-mediated resistant responses, but not the more subtle increase in virulence observed in the other interactions we investigated.
We hypothesize that avrRpt2 acts to promote virulence via two different mechanisms that could function simultaneously. The first, which involves interference between avrRpt2 and activation of R gene-mediated resistance responses, appears to be specific to RPM1 and results in complete inhibition of resistance. This mechanism may be similar to what has been proposed for P. syringae pv. phaseolicola virPphA, a gene that may promote virulence by inhibiting the induction of resistance responses in a cultivar (e.g., R gene)-specific manner. Interestingly, virPphA also has been demonstrated to function as an avr gene in soybean (Jackson et al. 1999 ).
The second mechanism by which we propose that avrRpt2 promotes virulence results in an increase in growth of PstDC3000 on several different A. thaliana lines. This mechanism may involve the modification or inhibition of a common component of the defense response, rather than interfering specifically with known R-gene-mediated resistance. Thus, although RPS4-and RPS5-mediated resistance responses appear to be properly induced in the presence of AvrRpt2, the transgenic plants are not able to mount a fully effective defense that results in complete restriction of pathogen growth. This second mechanism also could account for the enhanced bacterial growth observed in No-0 rps2 and the Col-0 cpr5 rps2 and coi1 rps2 mutants because resistance in these lines is attributed to the enhanced expression of defense responses in the absence of R-gene-mediated pathogen recognition (Boch et al. 1998; Bowling et al. 1997; A. Kloek, M. Lim, and B. Kunkel, unpublished) .
It is possible that these two virulence mechanisms could be mediated by modification of a single signaling component that is required for specific R-gene-mediated resistance and is involved in a common defense response pathway. In support of this hypothesis is the finding that some defense-signaling genes in A. thaliana may be involved in multiple aspects of defense. For example, the EDS1 gene is required both for resistance mediated by a subset of R-genes and for the limitation of growth of some virulent pathogens (Aarts et al. 1998 ). These findings suggest that EDS1 may encode a signaling component that is important for activation of R-gene-specific resistance as well as for the function of common defense responses. AvrRpt2 could promote virulence by interacting with a component of defense response signaling that functions in a similar manner.
Although we find the above hypothesis very attractive, we cannot rule out the possibility that avrRpt2 may promote the overall virulence of PstDC3000 via a mechanism that does not involve modification of host defense responses. Rather, AvrRpt2 may function by altering host physiology or metabolism in some other manner, perhaps by facilitating the production or release of nutrients for the bacterium, thereby rendering the host tissue more suitable for pathogen growth .
We currently favor the hypothesis that AvrRpt2 promotes the overall virulence of PstDC3000 by modifying a common component of the host defense response. We have demonstrated that infection of No-0 rps2 plants with PstDC3000 results in the production of mild disease symptoms and intermediate levels of pathogen growth (Fig. 1) . In preliminary experiments, we have observed that the moderate disease in No-0 plants is associated with the induction of a weak defense response upon infection with PstDC3000, including induction of pathogenesis-related gene expression and the accumulation of autofluorescent cell wall-bound phenolics, whereas infection with PstDC3000(avrRpt2) is not (A. Kloek, M. Lim, and B. Kunkel, unpublished) . These findings suggest that infection with PstDC3000(avrRpt2) results in the inhibition of these (and presumably other) host defense responses, thus providing the pathogen with a window of opportunity to grow and cause damage to host tissue. Although the mechanism by which avrRpt2 might accomplish this is not clear, one possibility is that AvrRpt2 may interact directly with a component of a defense-signaling pathway in the host in a manner similar to what has been observed for some virulence factors of mammalian pathogens (Finlay and Cossart 1997) . We are now in the process of investigating the mechanism(s) by which AvrRpt2 functions to promote bacterial virulence in plants.
MATERIALS AND METHODS

Bacterial strains and plasmids.
The bacterial pathogen Pseudomonas syringae pv. tomato (Pst) strain DC3000 and the avrRpt2, avrB, avrRpm1, avrRps4, and avrPphB (formerly avrPph3) avirulence genes have been described previously (Debener et al. 1991; Hinsch and Staskawicz 1996; Innes et al. 1993; Jenner et al. 1989; Staskawicz et al. 1987; Whalen et al. 1991) . The avrRpt2, avrB, avrRpm1, avrRps4, and avrPphB genes were introduced into PstDC3000 on plasmids pV288 (Whalen et al. 1991) , pVB01 , K48 (Debener et al. 1991), pV316-1A (Hinsch and Staskawicz 1996) , and pPPY424 (Fillingham et al. 1992) , respectively, by triparental mating using the helper plasmid pRK2013 (Figurski and Helinski 1979) . PstDC3000 strains not expressing cloned avr genes carried control plasmids pLAFR3 or pVSP61 (Staskawicz et al. 1987; Whalen et al. 1991) .
Plant material, growth conditions, and inoculation procedures.
A. thaliana ecotypes Columbia (Col-0) and Nossen (No-0) were used in this study. The susceptible rps2-201C and rps2-101C mutants and the cpr5-2 rps2-201C mutant line that exhibits enhanced disease resistance have been described previously (Boch et al. 1998; Kunkel et al. 1993; Yu et al. 1993) . The No-0 rps2-201C line was generated by crossing Col-0 rps2-201C plants with wild-type No-0 RPS2 plants. F 2 progeny from this cross homozygous for rps2-201C were used in four additional rounds of crossing to No-0 RPS2. Prior to performing each successive cross, plants carrying the rps2-201C allele were identified by using PG11, a closely linked molecular marker (Bent et al. 1994) . The heterozygous plants resulting from the fifth backcross to No-0 RPS2 were allowed to self-pollinate. F 2 progeny homozygous for rps2-201C were identified by assaying for the absence of RPS2-mediated resistance to PstDC3000(avrRpt2). The coi1-20 rps2-201C mutant line was isolated in a screen for mutants with enhanced resistance to PstDC3000(avrRpt2) and was shown by genetic complementation tests to carry a mutation at the COI1 locus (Feys et al. 1994; A. Kloek and B. Kunkel, unpublished) .
A. thaliana plants were maintained in growth chambers under an 8 h photoperiod at 24°C and 75% humidity. Mass inoculation of plants was carried out by dipping entire leaf rosettes into bacterial suspensions containing the surfactant Silwet L-77, as previously described . Disease symptoms were scored 4 days following inoculation. Bacterial growth within leaf tissue was monitored, as described by Whalen et al. (1991) . Pipette infiltrations to assay for the HR were carried out with PstDC3000 strains suspended in 10 mM MgCl 2 to a density of approximately 2 to 5 × 10 7 CFU/ml . Leaves were scored for tissue collapse 16 to 20 h after inoculation.
Generation of avrRpt2 transformation constructs.
The p35S-avrRpt2 transformation construct was generated by placing the avrRpt2 coding region under the control of the CaMV 35S promoter in the pMON10098 transformation vector (Klee et al. 1991) . The avrRpt2 coding region was engineered to have XbaI and NdeI restriction recognition sites at its 5′ end and an XhoI site at its 3′ end, using the polymerase chain reaction (PCR). Two primers, 5′GCTCTAGACATAT-GAAAATTGCTCCAGTTG-3′ (ZYC1) and 5′-CCGCTCGA-GGCGGTAGAGCATTGCG-3′ (ZYC2; restriction sites in bold and avrRpt2-homologous sequences underlined) were used to amplify the avrRpt2 coding region using pRSR0 ) DNA as the template. The resulting product was digested with NdeI and XhoI and cloned into pET-21b (Novagen, Madison, WI, U.S.A.) to generate plasmid pET21-avrRpt2, which carries an in-frame fusion of AvrRpt2 to a 6XHis tag at its carboxyl terminus. The resulting fusion was further engineered using PCR to have an XbaI site at the 5′ end and a BamHI site at the 3′ end of the avrRpt2-6XHis coding region. This was accomplished by using pET21-avrRpt2 DNA as the template, ZYC1 as the forward primer, and 5′-ACCGGATCCAGCCGGATCTCAGTGG-3′ (ZYC3, BamHI restriction site in bold and pET-21b-homologous sequences underlined) as the reverse primer. The resulting DNA product was digested with XbaI and BamHI and cloned into Bluescript KS(+). One resulting clone was used as a source of DNA to subclone the XbaI-BamHI fragment into pMON10098. To verify that the 6XHis tag did not affect AvrRpt2 avirulence and virulence activities, the avrRpt2-6XHis fusion was subcloned into the broad host-range vector pUCA12 (Kranz et al. 1997) , under the control of wild-type avrRpt2 regulatory sequences. The resulting clone, pUCA-12::avrRpt2-6XHis, was introduced into PstDC3000 by triparental mating and used to inoculate No-0 RPS2 and No-0 rps2-201C plants. Like PstDC3000 expressing the wild-type avrRpt2 gene, PstDC3000 carrying pUCA12::avrRpt2-6XHis elicited a normal HR on No-0 RPS2 plants and exhibited enhanced virulence on No-0 rps2-201C plants.
The pRPS2-avrRpt2 fusion was generated by subcloning the approximately 1.4-kb region of genomic DNA upstream of the RPS2 coding region from pBI1.R2 (Mindrinos et al. 1994) into pBI121 (Clontech, Palo Alto, CA) such that the RPS2 upstream region and a multiple cloning site replaced the Fig. 4 . RPS4-or RPS5-mediated resistance responses are induced in transgenic plants expressing avrRpt2. A, Levels of Pseudomonas syringae pv. tomato strain DC3000, PstDC3000 expressing avrRps4, and PstDC-3000 expressing avrPphB 4 days after inoculation in Col-0 rps2 plants carrying the pRPS2-avrRpt2 construct. B, Levels of PstDC3000(avrRps4) and Pst-DC3000(avrPphB) 4 days after inoculation in untransformed Col-0 rps2 plants (white bars) and Col-0 rps2 plants carrying the pRPS2-avrRpt2 construct (black bars). Each bar represents the mean and standard error of three independent replicate samples. The plants were inoculated by vacuum infiltration with the indicated PstDC3000 strains at an initial density of 1 × 10 5 CFU/cm CaMV 35S promoter and the GUS gene of pBI121. The avrRpt2 coding region from pKExavrRpt2 (Leister et al. 1996) was cloned into the multiple cloning site of the resulting plasmid to generate pBI1.Rpro11-avrRpt2, which contains the avrRpt2 gene under control of the RPS2 upstream region.
Plant transformations.
No-0 rps2-201C and Col-0 rps2-101C plants were transformed by the Agrobacterium sp. floral dipping procedure as described by Clough and Bent (1998) , with the exception that A. tumefaciens strain ABI was used to deliver the p35S-avrRpt2 construct (Klee et al. 1991) . Primary transformants (T1) were selected on 0.5× MS media (Murashige and Skoog 1962) plates containing 50 µg of kanamycin (Sigma, St. Louis, MO, U.S.A.) per ml. Several kanamycin-resistant seedlings for each construct were selected and allowed to self-fertilize to generate T 2 progeny. The number of insertion sites present in each transformation event was determined by monitoring the segregation of kanamycin resistance in the T 2 progeny. Homozygous T 2 plants from lines carrying a single insertion were identified by progeny testing. For each construct, several lines determined to be homozygous for insertions at a single locus were selected for further analysis.
The expression and avr activity of the pRPS2-avrRpt2 and p35S-avrRpt2 constructs in the transgenic plants were assayed by crossing the transgenic plant lines to wild-type plants carrying a functional RPS2 gene. The F 1 progeny from these crosses were germinated on 0.5× MS plates containing kanamycin to assay for survival. The progeny derived from crosses with several different transgenic lines died at 2 to 3 weeks of age, presumably as a result of the induction of a systemic HR triggered by the avrRpt2/RPS2 interaction. F 1 plants from control crosses in which the transgenic plants were crossed to plants carrying a mutant RPS2 allele did not exhibit this lethal phenotype. The transgenic lines that gave rise to F 1 progeny that died in these experiments were chosen for further experimentation. Expression of avrRpt2 in these transgenic plants was verified by RNA blot analysis (Sambrook et al. 1989) . In No-0 rps2-201C p35S-avrRpt2 transgenic plants, expression of avrRpt2 also was monitored by protein gel blot analysis (Sambrook et al. 1989 ) using antiAvrRpt2 antibodies (McNellis et al. 1998) . In these transgenic lines, expression of avrRpt2 resulted in the accumulation of an approximately 27 kDa AvrRpt2 protein, which is significantly smaller than that observed for the full-length fusion protein (approximately 36 kDa). This result is consistent with previous reports that the AvrRpt2 protein is subject to N-terminal processing in plant cells. This proteolytic processing has been observed in transgenic plants expressing avrRpt2 and in protein extracts from A. thaliana plants infected with PstDC-3000(avrRpt2) (McNellis et al. 1998; Mudgett and Staskawicz 1999) .
The avrRpt2 transgene was introduced into the cpr5 rps2 mutant line by crossing with Col-0 rps2 transgenic plants carrying the pRPS2-avrRpt2 construct. The resulting F 1 plants were allowed to self-fertilize, and the F 2 seeds were collected and plated onto 0.5× MS plates containing kanamycin to select for plants carrying pRPS2-avrRpt2. The resulting kanamycin-resistant plants were then screened to identify plants homozygous for the cpr5-2 mutation by assaying for the appearance of spontaneous necrotic lesions and enhanced resistance to PstDC3000 (Boch et al. 1998) . Kanamycin-resistant plants that were homozygous for cpr5-2 were allowed to selffertilize, and the resulting progeny was assayed for kanamycin resistance to identify lines that were homozygous for the pRPS2-avrRpt2 transgene.
